1. Home
  2. ASG vs EOLS Comparison

ASG vs EOLS Comparison

Compare ASG & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty All-Star Growth Fund Inc.

ASG

Liberty All-Star Growth Fund Inc.

HOLD

Current Price

$5.30

Market Cap

341.5M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.01

Market Cap

384.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASG
EOLS
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.5M
384.6M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
ASG
EOLS
Price
$5.30
$6.01
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
261.3K
711.4K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$4.55
$3.86
52 Week High
$5.69
$7.95

Technical Indicators

Market Signals
Indicator
ASG
EOLS
Relative Strength Index (RSI) 54.56 47.73
Support Level $5.26 $6.01
Resistance Level $5.35 $6.34
Average True Range (ATR) 0.11 0.27
MACD 0.01 0.02
Stochastic Oscillator 72.09 68.02

Price Performance

Historical Comparison
ASG
EOLS

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company's portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: